Research Insight
Trophos will present results of pivotal phase II/III study of olesoxime in spinal muscular atrophy patients at the American Academy of Neurology
Trophos and AFM-Telethon (The French Muscular Dystrophy Association) today announce that data from the pivotal clinical trial of Trophos’ lead product candidate olesoxime in...
News
Pfizer confirms £60bn bid interest in AstraZeneca
US-based drug maker Pfizer has confirmed that it has contacted AstraZeneca seeking to renew discussions over a possible £60bn takeover. The...
News
Alexion begins multinational registration trials of eculizumab to treat NMO and MG
US-based Alexion Pharmaceuticals has started a single, multinational, placebo-controlled trial designed to assess the safety and efficacy of eculizumab (Soliris) in patients with relapsing...
Techno Trends
DNA Electronics Secures Funding From Genting Berhad To Develop Genalysis® Point-of-Care Genomic Diagnostics Product Line
DNA Electronics Ltd (DNAe), a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that it had successfully secured the necessary...
News
Eli Lilly’s Cyramza becomes first FDA-approved gastric cancer drug
Eli Lilly has obtained US Food and Drug Administration approval for its Cyramza (ramucirumab) as a single-agent treatment for patients with advanced or metastatic...
Press Releases
Telstar Introduces Biodecontamination Technology for Aseptic Systems
Telstar has introduced the new ionHP biodecontamination system for use in pharmaceutical aseptic enclosures, an innovative technology which resolves some of the traditional difficulties...
News
Abbvie starts Phase III trial of lung cancer drug veliparib
US-based biopharmaceutical firm AbbVie has started a global Phase III clinical trial of an investigational oral poly (adenosine diphosphate -ribose) polymerase (PARP) inhibitor 'veliparib...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read